Seres Therapeutics MCRB Income Statement (2014-2026)

NASDAQ MCRB
$4.57 -0.11 (-2.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Revenue & cost
Revenue (Quarter)
0.13B0.01B0.00B0.00B0.00B0.00B0.00B0.13B0.00B-0.13B0.00B0.00B0.00B0.00B
Operating items
Research & Development (Quarter)
0.04B0.04B0.04B0.04B0.04B-0.02B0.02B0.05B0.03B0.02B0.02B0.02B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Selling, General & Administrative (Quarter)
0.02B0.02B0.02B0.02B0.02B0.01B0.02B0.03B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
0.00B0.00B0.00B-0.00B0.00B-0.00B0.03B0.00B0.00B0.00B0.00B0.00B0.00B0.03B
Operating Expenses (Quarter)
0.06B0.06B0.06B0.06B0.06B-0.00B0.07B0.08B0.04B0.04B0.03B0.03B0.03B0.03B0.03B0.02B0.02B0.02B0.02B0.02B
Operating Income (Quarter)
0.07B-0.05B-0.06B-0.06B-0.06B-0.00B-0.07B0.05B-0.04B-0.04B-0.03B-0.03B-0.03B-0.03B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B
EBIT (Quarter)
0.07B-0.05B-0.06B-0.06B-0.06B-0.00B-0.07B0.05B-0.04B-0.04B-0.03B-0.03B-0.03B-0.03B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.01B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B0.00B-0.02B0.01B0.01B0.00B0.00B0.00B0.00B0.00B
Non Operating Income (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B-0.02B0.01B0.06B0.01B0.03B0.00B0.00B0.03B
Net income details
EBT (Quarter)
-19.81B-0.05B-0.06B-0.92B-16.47B-0.06B-0.07B0.04B-0.05B-0.05B-0.04B-0.03B-0.03B-0.04B-0.03B-0.15B-0.15B-0.02B-0.03B-0.10B
Profit After Tax (Quarter)
0.07B-0.05B-0.06B-0.06B0.00B0.00B-0.07B0.05B-0.04B-0.04B-0.04B-0.03B0.09B0.11B0.03B-0.02B0.01B-0.02B-0.02B0.00B
Income from Continuing Operations (Quarter)
-19.81B-0.05B-0.06B-0.92B-16.47B-0.06B-0.07B0.04B-0.05B-0.05B-0.04B-0.03B-0.03B-0.04B-0.03B-0.15B-0.15B-0.02B-0.03B-0.10B
Consolidated Net Income (Quarter)
-19.81B-0.05B-0.06B-0.92B-16.47B-0.06B-0.07B0.04B-0.01B-0.01B-0.01B-0.01B0.14B-0.03B-0.10B
Income towards Parent Company (Quarter)
-19.81B-0.05B-0.06B-0.92B-16.47B-0.06B-0.07B0.04B-0.01B-0.01B-0.01B-0.01B0.14B-0.03B-0.10B
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-19.81B-0.05B-0.06B-0.92B-16.47B-0.06B-0.07B0.05B-0.01B-0.01B-0.01B-0.03B0.14B-0.03B-0.10B
Additional items
EPS (Basic) (Quarter)
-0.00B-10.84-12.47-198.81-0.00B-11.17-11.757.29-1.07-1.02-0.99-4.3418.32-2.67-10.14
EPS (Diluted) (Quarter)
-0.00B-10.84-12.47-198.81-0.00B-11.17-11.757.17-1.07-1.02-0.99-4.3418.32-2.67-10.10
Shares Outstanding (Quarter)
0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Shares Outstanding (Diluted) (Quarter)
0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
EBITDA (Quarter)
0.07B-0.05B-0.06B-0.06B-0.06B-0.00B-0.07B0.05B-0.04B-0.04B-0.03B-0.03B-0.03B-0.03B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B
Interest Expenses (Quarter)
19.88B0.00B0.00B0.85B16.41B0.06B0.00B0.01B0.00B0.01B0.00B0.01B0.01B0.01B0.00B0.13B0.12B0.00B0.08B